Literature DB >> 17708908

Cell-cycle control: POLO-like kinases join the outer circle.

H A Lane1, E A Nigg.   

Abstract

Named after the polo gene of Drosophila, POLO-like kinases (PLKs) constitute a novel, evolutionarily conserved family of essential cell-cycle regulators. As emphasized in this review, recent studies identify important roles for vertebrate PLKs at the onset of mitosis: Plx1, a Xenopus PLK, has been implicated in the activation of Cdc25 phosphatase (and hence the activation of Cdc2), while human Plk1 is required for the proper maturation of the poles of mitotic spindles. These studies suggest a major role for Plk1/Plx1 in coordinating spindle assembly with the activation of Cdc2-cyclin complexes, and they establish a direct link between PLKs and the core cell-cycle-regulatory machinery. Genetic and biochemical studies in yeasts and Drosophila point to additional roles for PLKs at later stages of mitosis. Finally, mammals express multiple PLKs, suggesting that different family members might function at distinct cell-cycle transitions, reminiscent of cyclin-dependent kinases.

Entities:  

Year:  1997        PMID: 17708908     DOI: 10.1016/S0962-8924(96)10051-9

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  26 in total

1.  Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures.

Authors:  S Song; T Z Grenfell; S Garfield; R L Erikson; K S Lee
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Phosphorylation of Ran-binding protein-1 by Polo-like kinase-1 is required for interaction with Ran and early mitotic progression.

Authors:  Hyo-In Hwang; Jae-Hoon Ji; Young-Joo Jang
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

3.  Role of Polo-like kinase 1 in the regulation of the action of p31comet in the disassembly of mitotic checkpoint complexes.

Authors:  Sharon Kaisari; Pnina Shomer; Tamar Ziv; Danielle Sitry-Shevah; Shirly Miniowitz-Shemtov; Adar Teichner; Avram Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

4.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.

Authors:  J R Bischoff; L Anderson; Y Zhu; K Mossie; L Ng; B Souza; B Schryver; P Flanagan; F Clairvoyant; C Ginther; C S Chan; M Novotny; D J Slamon; G D Plowman
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.

Authors:  Nobumoto Watanabe; Harumi Arai; Jun-Ichi Iwasaki; Masaaki Shiina; Kazuhiro Ogata; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

6.  The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts.

Authors:  P Descombes; E A Nigg
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

7.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein.

Authors:  A Gallina; L Simoncini; S Garbelli; E Percivalle; G Pedrali-Noy; K S Lee; R L Erikson; B Plachter; G Gerna; G Milanesi
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Inhibition of endocytic vesicle fusion by Plk1-mediated phosphorylation of vimentin during mitosis.

Authors:  Keisuke Ikawa; Ayaka Satou; Mitsuko Fukuhara; Shigeru Matsumura; Naoyuki Sugiyama; Hidemasa Goto; Mitsunori Fukuda; Masaki Inagaki; Yasushi Ishihama; Fumiko Toyoshima
Journal:  Cell Cycle       Date:  2013-10-25       Impact factor: 4.534

10.  Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk.

Authors:  K S Lee; T Z Grenfell; F R Yarm; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.